Literature DB >> 8491548

Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases.

K Matsumoto1, N B Shams, L A Hanninen, K R Kenyon.   

Abstract

PURPOSE: To examine the effect of Pseudomonas aeruginosa on the expression of corneal matrix metalloproteases and the effect of its proteases on activation of corneal matrix metalloproteases in vitro.
METHODS: Rat corneas and human corneal fibroblasts were co-cultivated with two different strains (RPS & 599A) of P. aeruginosa and one strain of Staphylococcus aureus, and the conditioned media were analyzed for proteolytic activity by gelatin and casein zymography. Human corneal fibroblast-conditioned medium was incubated with that from either strain of P. aeruginosa and was analyzed in a similar manner.
RESULTS: Normal rat corneas in organ culture produce a 65 kDa gelatinase (inactive matrix metalloprotease-2), whereas thermally injured rat corneas additionally produce gelatinases with molecular masses of 92 kDa (inactive matrix metalloproteases-9) and > 200 kDa. Matrix metalloprotease-2 is also detected in human corneal fibroblast-conditioned medium. Although these matrix metalloproteases are no longer detectable when rat corneas or human corneal fibroblasts are co-cultured with two strains of P. aeruginosa for 48 hr, a 58 kDa gelatinase fragment appears in earlier stages of co-culture. In contrast, S. aureus does not affect matrix metalloprotease-2. The 58 kDa fragment is also evident by incubating human corneal fibroblast-conditioned medium with that from either strain of P. aeruginosa. Conditioned medium from the RPS strain, which produces both elastase and alkaline protease, is more effective in cleaving matrix metalloprotease-2 than that from the 599A strain, which expresses mainly alkaline protease.
CONCLUSION: The secreted inactive corneal matrix metalloprotease-2 is activated through limited proteolysis by pseudomonal proteases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491548

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice.

Authors:  J A Hobden; S A Masinick; R P Barrett; L D Hazlett
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

2.  Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors.

Authors:  J A Lomholt; K Poulsen; M Kilian
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease.

Authors:  E H Burns; A M Marciel; J M Musser
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections.

Authors:  M J Preston; P C Seed; D S Toder; B H Iglewski; D E Ohman; J K Gustin; J B Goldberg; G B Pier
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor.

Authors:  Aihua Tang; Armando R Caballero; Mary E Marquart; Richard J O'Callaghan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-17       Impact factor: 4.799

6.  Involvement of bradykinin generation in intravascular dissemination of Vibrio vulnificus and prevention of invasion by a bradykinin antagonist.

Authors:  K Maruo; T Akaike; T Ono; H Maeda
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis).

Authors:  James Chodosh
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen.

Authors:  J A Hobden; J M Hill; L S Engel; R J O'Callaghan
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

9.  Modulation of corneal and stromal matrix metalloproteinase by the mannose-induced Acanthamoeba cytolytic protein.

Authors:  Hassan Alizadeh; Haochuan Li; Sudha Neelam; Jerry Y Niederkorn
Journal:  Exp Eye Res       Date:  2008-06-25       Impact factor: 3.467

10.  Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion.

Authors:  J L Kadurugamuwa; T J Beveridge
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.